FDA Inspection 1152144 — Sichuan Qingmu Pharmaceutical Co., Ltd
The FDA completed an inspection of Sichuan Qingmu Pharmaceutical Co., Ltd on Sep 7, 2021 in Meishan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 7, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Meishan (China)